Status:
UNKNOWN
The Therapeutic Effect of BET in COM With ETD
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Balloon Eustachian Tuboplasty
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Currently, surgical treatment of patients with chronic otitis media is one of the most important treatment methods. However, the current results show that some patients with eustachian tube dysfunctio...
Eligibility Criteria
Inclusion
- Patients who need tympanoplasty, with clear diagnosis of chronic otitis media, middle ear cholesteatoma;
- Patients with eustachian tube dysfunction using TMM;
- Subjects or their legal representatives can understand the purpose of the study, show sufficient compliance with the research protocol, and sign the informed consent form.
Exclusion
- Secondary chronic otitis media (after head and neck cancer radiotherapy);
- Ipsilateral ear recurrence after surgical treatment, requiring secondary surgery;
- Two tympanoplasty surgery;
- Typical allergic rhinitis, nasal endoscopy or imaging studies suggest chronic rhinosinusitis, nasal polyps and other short-term eustachian tube function of a greater impact on the disease;
- poor general health, with severe liver and kidney dysfunction, coagulation disorders, cardiovascular disease, neurological diseases can not tolerate surgery.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03440710
Start Date
June 1 2018
End Date
December 30 2019
Last Update
February 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China
Shanghai, Shanghai Municipality, China, 200031